Xenetic Biosciences Inc. (XBIO)
4.00
0.08 (2.04%)
At close: Mar 03, 2025, 3:38 PM
4.06
1.50%
After-hours: Mar 03, 2025, 03:24 PM EST
Xenetic Biosciences Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -1.28 | -0.63 | -2.39 | -1.2 | -0.26 | -2.04 | -4.63 | -0.59 | -1.72 | -1.47 | -0.22 | -0.29 | n/a |
| PEG Ratio | 0.03 | 0.04 | 0.03 | 0.02 | 0.01 | -0.02 | 0.05 | -0.00 | 0.12 | 0.02 | -0.01 | n/a | n/a |
| PS Ratio | 2.08 | 2.38 | 11.42 | 29.84 | 240.69 | n/a | 2.19 | 10.65 | n/a | n/a | 1.85 | 6.31 | n/a |
| PB Ratio | 0.54 | 0.30 | 0.72 | 1.07 | 0.24 | 1.50 | 1.16 | 1.98 | 3.26 | 2.00 | 0.15 | 0.09 | n/a |
| P/FCF Ratio | -1.28 | -0.79 | -2.8 | -3.06 | -0.64 | -2.3 | 11.20 | -3.63 | -4.06 | -1.7 | -0.3 | -0.29 | n/a |
| P/OCF Ratio | -1.28 | -0.87 | -2.8 | -3.06 | -0.64 | -2.3 | 11.13 | -3.64 | -4.06 | -1.7 | -0.31 | -0.3 | n/a |
| OCF/S Ratio | -1.62 | -2.72 | -4.08 | -9.77 | -374.98 | n/a | 0.20 | -2.93 | n/a | n/a | -6.05 | -21.33 | n/a |
| Debt / Equity Ratio | n/a | n/a | 0.00 | 0.01 | 0.00 | n/a | n/a | n/a | 0.06 | 0.04 | 0.05 | 0.03 | 120.57 |
| Quick Ratio | 11.84 | 12.72 | 13.18 | 13.20 | 7.84 | 0.75 | 3.03 | 4.47 | 0.57 | 1.03 | 1.48 | 8.25 | 1.26 |
| Current Ratio | 11.84 | 12.72 | 13.18 | 13.20 | 7.84 | 0.75 | 3.03 | 4.47 | 0.57 | 1.03 | 1.48 | 8.25 | 1.26 |
| Asset Turnover | 0.24 | 0.12 | 0.06 | 0.03 | 0.00 | n/a | 0.40 | 0.14 | n/a | n/a | 0.05 | 0.01 | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | -301.53 | -1.96K | -65.01 | -36.79 | -2.75K | -13.63K | -122.62 | n/a |
| Return on Equity (ROE) | -0.42 | -0.47 | -0.3 | -0.89 | -0.93 | -0.74 | -0.25 | -3.35 | -1.89 | -1.37 | -0.68 | -0.3 | n/a |
| Return on Assets (ROA) | -0.39 | -0.43 | -0.28 | -0.83 | -0.74 | -0.51 | -0.19 | -2.58 | -0.74 | -0.88 | -0.44 | -0.25 | n/a |
| Return on Capital (ROIC) | -0.46 | -0.49 | -0.31 | 0.37 | -0.64 | -0.57 | -0.21 | -2.48 | -1.03 | -0.95 | -0.54 | -0.26 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 98.42% | 96.94% | 100.00% | 100.00% | n/a | 97.94% | 98.79% | n/a | n/a | 99.16% | 84.73% | n/a |
| Net Profit Margin | -162.78% | -374.17% | -477.71% | -2.49K% | -93.46K% | n/a | -47.4% | -1.81K% | n/a | n/a | -857.92% | -2.16K% | n/a |
| Pretax Profit Margin | -162.78% | -383.87% | -486.36% | -3.16K% | -74.86K% | n/a | -47.4% | -1.81K% | n/a | n/a | -857.92% | -2.16K% | n/a |
| Operating Profit Margin | -177.79% | -393.57% | -495.12% | 1.04K% | -75.51K% | n/a | -47.05% | -1.58K% | n/a | n/a | -861.35% | -2.16K% | n/a |
| FCF Margin | -161.98% | -301.52% | -408.21% | -976.6% | -37.5K% | n/a | 19.58% | -293.47% | n/a | n/a | -613.07% | -2.18K% | n/a |
| EBITDA Margin | -178.9% | -393.57% | -492.06% | -1.07K% | -56.11K% | n/a | -47.06% | -1.78K% | n/a | n/a | -852.66% | -1.72K% | n/a |